Mechanistically, lipocalin 2 reduced intracellular iron levels and stimulated the expression of GPX4 and SLC7A11.[111] Treatment of CRC cells with tagitinin C inhibited cell growth, induced oxidation of the cellular microenvironment, and enhanced ferroptosis. Here, LCN2 is linked to colorectal carcinoma.